Review Article

State of the science in diabetic foot: subjective screening vs. objective diabetic neuropathy examination in primary care

Rafael Medrano Jiménez* and Mª del Mar Gili Rius

Published: 14 October, 2022 | Volume 6 - Issue 2 | Pages: 049-051

Among the conditioning factors of Diabetic Foot (DF), neuropathy is considered the main factor, arteriopathy the aggravating factor, and foot deformities the triggering factor. The preventive interventions for DF and its complications are distributed by levels of care. At the higher level, hospital care focuses on reducing DF amputations. At the lower level, Primary Care (PC) and Podiatry, focused on preventing DF. PC is considered the ideal place to identify the conditioning factors of DF. In this area, prevention follows the recommendations of the International Working Group on Diabetic Foot (IWGDF) by screening neuropathy focused on the sensitive or insensitive foot. The American Diabetes Association (ADA) a recommends person-centered assessment of neuropathy by clinical examination of symptoms and signs testing sensory, motor, and autonomic neuropathy. This controversy lead us to investigate which methodology (screening or clinical examination) could be more accurate in identifying the conditioning factors of DF in a group of people recruited in the TERMOPIEDI study. Neuropathy was assessed following the definition of diabetic neuropathy, the Young MJ diagnostic criteria, and the Toronto Council diagnostic category. These results allowed us to know the applicability of this procedure in PC within nursing competencies, detecting a greater number of patients with neuropathy compared to the screening method. People with neuropathy presented higher plantar temperature, concluding that neuropathy interferes with foot thermoregulation.

Read Full Article HTML DOI: 10.29328/journal.jnnd.1001069 Cite this Article Read Full Article PDF


Diabetic foot; Neuropathy; Primary care


  1. Schaper NC, van Netten JJ, Apelqvist J, Sicco A. Bus, Robert J. Hinchliffe, Benjamin A. Lipsky on behalf of the International Working Group on the Diabetic Foot (IWGDF)IWGDF Practical guidelines on the prevention and management of diabetic foot disease. Part of the 2019 IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease.
  2. American Diabetes Association. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S135-S151. doi: 10.2337/dc20-S011. PMID: 31862754.
  3. Reig-Viader R, Espallargues M. Review and proposal of the diabetic foot care model in Catalonia. Barcelona: Health Quality and Evaluation Agency of Catalonia. Department of Health. Government of Catalonia; 2019.
  4. Khunkaew S, Fernandez R, Sim J. Health-related quality of life among adults living with diabetic foot ulcers: a meta-analysis. Qual Life Res. 2019 Jun;28(6):1413-1427. doi: 10.1007/s11136-018-2082-2. Epub 2018 Dec 18. PMID: 30565072.
  5. Rubio JA, Jiménez S, Álvarez J. Clinical characteristics and mortality of patients cared for in a Multidisciplinary Diabetic Foot Unit. Endocrinology, Diabetes and Nutrition. 2017; 64(5): 241-249. doi: 10.1016 / j.endinu.2017.02.012
  6. Jiménez S, Rubio JA, Álvarez J, Lázaro-Martínez JL. An Analysis of reulcerations in a multidisciplinary unit of diabetic foot after the implementation of an integrated foot care program. Endocrinolog, Diabet and Nutrition. 2018; doi: 10.1016/ j.endinu.2018.03.012
  7. Jiménez S, Rubio JA, Álvarez J, Ruiz Grande F. Trend in the incidence of lower limb amputations after the implementation of a Multidisciplinary Diabetic Foot Unit. Endocrinology, Diabetes and Nutrition. 2017; 64(4): 188–197.
  8. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis . Ann Med. 2017 Mar;49(2):106-116. doi: 10.1080/07853890.2016.1231932. Epub 2016 Nov 3. PMID: 27585063.
  9. Tardáguila-García A, García-Morales E, García-Alamino JM, Álvaro-Afonso FJ, Molines-Barroso RJ, Lázaro-Martínez JL. Metalloproteinases in chronic and acute wounds: A systematic review and meta-analysis. Wound Repair Regen. 2019 Jul;27(4):415-420. doi: 10.1111/wrr.12717. Epub 2019 Mar 27. PMID: 30873727.
  10. Shu X, Shu S, Tang S, Yang L, Liu D, Li K, Dong Z, Ma Z, Zhu Z, Din J. Efficiency of stem cell based therapy in the treatment of diabetic foot ulcer: a meta-analysis. Endocr J. 2018 Apr 26;65(4):403-413. doi: 10.1507/endocrj.EJ17-0424. Epub 2018 Jan 22. PMID: 29353870.
  11. Alonso Fernández M, Mediavilla Bravo JJ, López Simarro F, Comas Samper JM, Carramiñana Barrera F, Mancera Romero J. Assessment of diabetic foot screening in Primary Care. Endocrinol. Nutr. 2014;61(6):311-317.
  12. Dyck PJ, Herrmann DN, Staff NP, Dyck PJ. Assessing decreased sensation and increased sensory phenomena in diabetic polyneuropathies. Diabetes. 2013 Nov;62(11):3677-86. doi: 10.2337/db13-0352. PMID: 24158999; PMCID: PMC3806590.
  13. International Classification of Diseases 10th Revision, Clinical Modification. 4th Spanish edition Ministry of Health. https://eciemaps.mscbs.gob.es/ecieMaps/browser/index_10_mc.html
  14. Crawford F, Nicolson DJ, Amanna AE, Martin A, Gupta S, Leese GP, Heggie R, Chappell FM, McIntosh HH. Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data. Diabetologia. 2020 Jan;63(1):49-64. doi: 10.1007/s00125-019-05020-7. Epub 2019 Nov 27. PMID: 31773194; PMCID: PMC6890632.
  15. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993 Feb;36(2):150-4. doi: 10.1007/BF00400697. PMID: 8458529.
  16. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010 Oct;33(10):2285-93. doi: 10.2337/dc10-1303. Erratum in: Diabetes Care. 2010 Dec;33(12):2725. PMID: 20876709; PMCID: PMC2945176.
  17. Medrano Jiménez R, Gili Rius MM, García Castillo O, Ruiz Messeguer M, Medrano Baeza B, Anglà Vendrell M. Plantar thermometry and diabetic foot risk in primary care. Results of the thermopiedi study. Butlletí.
  18. Medrano Jiménez R, Gili Riu MM, Herrera Diaz MA. Identify the risk foot in patients with diabetes. A space for improvement in primary care, Family Medicine. Semergen. 2022. https://doi.org/10.1016/j.semerg.2022.01.007
  19. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A. North-West Diabetes Foot Care Study representation. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002 May;19(5):377-384.


Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?